Abstract:Objective To observe the effect of dichloroacetate (DCA) on pulmonary arterial pressure and the expression of survivin in rat model of severe pulmonary arterial hypertention(PAH).Methods 40 male Sprague-Dawley rats (8-wk-old,weight 200 g-250 g) were randomly divided into 5 goups,each of which had eight rats:normal group (N),dichloroacetate control group (D),left pneumonectom (PE)+ monocrotaline (MCT)group (PM),early DCA treated group (PMD1),and later DCA treated group (PMD2).Except for group N and D,other groups were induced by pneumonectomy combined with monocrotaline 60 mg/kg subcutaneous injection after pneumonectomy(D14).Group PMD1 and PMD2 were respectively received dichloroacetate 80 mg· kg-1·d-1 after pneumonectomy (D14) and D35 by intragastric gavage once a day for 21 consecutive days.At the same time,the equivalent volume of sterile saline solution was substituted for DCA in group PM.Rats in group D were treated as same as in group N except for receiving DCA gavage treatment as described in group PMD.At D35 (PMD1)and D56 (PMD2).Pulmonary arterial pressure was measured by direct puncture of pulmonary artery trunk with i.v.Catheter (22 gauge) connected to pressure transducer.Rats were euthanized by intravenous injection with potassium chloride,and inferior lobe of right lung were dissected,snap-frozen in the liquid nitrogen and kept at-80 ℃ until analyzed.The residual lobes were fixed in neutral formaldehyde for further HE stain and morphometric analysis.The mRNA expression of survivin was analyzed with realtime-PCR.The protein expression of survivin was detected with Western blot.Results The mean PAP of group PM is (37.8±1.3) mm Hg (1 mm Hg=0.133 kPa),the percentage of medial thickening (WT％) and right ventricular hypertrophy index (RV/LV+S) are (40±8)％ and (44.8±2.2),respectively.The expression of survivin mRNA and protein level are(4.03±0.27) and(0.684±0.055),respectively.Compared with group N and group D,they were markedly increased in group PM (P＜0.05).Early treatment with DCA significandy reduced the mean PAP,the percentage of medial thickening,and right ventricular hypertrophy index,they are (26.2±1.5) mm Hg,(24±3)％,and (29.5±1.9),respectively.Meanwhile,the expression of survivin mRNA and protein level were markedly reduced to (2.00±0.12) and (0.415±0.027),compared with group PM,they were significantly reduced in group PMD1 (P＜0.05).Whereas later treatment with DCA has no significant effect (P＞0.05),the mean PAP,the percentage of medial thickening,and right ventricular hypertrophy index are (36.0± 1.6) mm Hg,(38±3)％,and (42.0±1.3),respectively.The expression of survivin mRNA and protein level were (3.77±0.45) and (0.732±0.101),respectively.Conclusions Survivin plays an important role in the development of pulmonary hypertention and the remodeding of pulmonary vascular.DCA alleviates the deterioration of PAH,medial thickening of pulmonary arterioles and protein expression of survivin in pneumonectomized rats injected with MCT,whereas there were no significant difference was found between PM and PMD2.

Effect of dimethyl 4-(2-chlorophenyl)-1,4-dihydro-2,6-dimethyl-3, 5-pyridinedicarboxylate on the chronic pulmonary hypertension induced by monocrotaline in rats

Systemic Evaluation of Platelet and Leukocyte Activation and Interaction in A Rat Model of Pulmonary Arterial Hypertension

Interruption of CD40 Pathway Improves Efficacy of Transplanted Endothelial Progenitor Cells in Monocrotaline Induced Pulmonary Arterial Hypertension.

Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition

Effects of T-type Calcium Channel Inhibitors on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

The expression of survivin in dichloroacetate treatment of pulmonary hypertention

Effects of Endogenous Sulfur Dioxide on Monocrotaline-Induced Pulmonary Hypertension in Rats.

Effects of Lipoxin Receptor Agonist BML-111 on Pulmonary Arterial Hypertension of Rats Induced by Monocrotaline

Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-kappa B pathways

TPN171H alleviates pulmonary hypertension via inhibiting inflammation in hypoxia and monocrotaline-induced rats

Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways

[Effect of Elastase Inhibitor on Pulmonary Hypertension Induced by Monocrotaline].

Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension

Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats

The Effects of 14-Day Oral Exposure to Dimethoate on Cardiovascular Systems in Spontaneously Hypertensive Rats

Dichloroacetate prevents but not reverses the formation of neointimal lesions in a rat model of severe pulmonary arterial hypertension.

Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling

Celastrol Attenuates the Remodeling of Pulmonary Vascular and Right Ventricular in Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats.

Effects of endogenous sulfur dioxide on pulmonary vascular inflammation in rats with monocrotaline-induced pulmonary hypertension

H 2 S inhibits pulmonary arterial endothelial cell inflammation in rats with monocrotaline-induced pulmonary hypertension

Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response